News Related to PPV

Related coverage linked through entity extraction aliases.

Grail's NHS-Galleri Cancer Screening Trial Misses Primary Endpoint

Mar 09, 2026

Grail's NHS-Galleri trial of 142,000 participants failed to achieve statistically significant reduction in late-stage cancer diagnoses, though secondary endpoints showed four-fold improvement in overall cancer detection rate. Stock fell 48% following the announcement.

Lilly's Retevmo Shows Significant Event-Free Survival Benefit in Early-Stage Lung Cancer Trial

Feb 16, 2026

Eli Lilly announced positive Phase 3 LIBRETTO-432 trial results showing Retevmo (selpercatinib) significantly improved event-free survival in patients with early-stage RET fusion-positive non-small cell lung cancer as adjuvant therapy.